595 related articles for article (PubMed ID: 19294700)
1. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
3. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
4. Lectin-based proteomic profiling of aged skeletal muscle: decreased pyruvate kinase isozyme M1 exhibits drastically increased levels of N-glycosylation.
O'Connell K; Doran P; Gannon J; Ohlendieck K
Eur J Cell Biol; 2008 Oct; 87(10):793-805. PubMed ID: 18602720
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
6. Comparative glycoproteomics based on lectins affinity capture of N-linked glycoproteins from human Chang liver cells and MHCC97-H cells.
Xu Z; Zhou X; Lu H; Wu N; Zhao H; Zhang L; Zhang W; Liang YL; Wang L; Liu Y; Yang P; Zha X
Proteomics; 2007 Jul; 7(14):2358-70. PubMed ID: 17623300
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
8. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
9. Identification and analysis of alpha1,6-fucosylated proteins in human normal liver tissues by a target glycoproteomic approach.
Dai Z; Fan J; Liu Y; Zhou J; Bai D; Tan C; Guo K; Zhang Y; Zhao Y; Yang P
Electrophoresis; 2007 Dec; 28(23):4382-91. PubMed ID: 18041034
[TBL] [Abstract][Full Text] [Related]
10. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
11. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
[TBL] [Abstract][Full Text] [Related]
12. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum.
Zhao J; Simeone DM; Heidt D; Anderson MA; Lubman DM
J Proteome Res; 2006 Jul; 5(7):1792-802. PubMed ID: 16823988
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
[TBL] [Abstract][Full Text] [Related]
14. Reduced transthyretin expression in sera of lung cancer.
Liu L; Liu J; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
Cancer Sci; 2007 Oct; 98(10):1617-24. PubMed ID: 17683510
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
16. [Application of proteomics to diagnosis and treatment of lung cancer].
Dai M; Luo RC
Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
[TBL] [Abstract][Full Text] [Related]
17. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
[TBL] [Abstract][Full Text] [Related]
18. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.
Tsai HY; Boonyapranai K; Sriyam S; Yu CJ; Wu SW; Khoo KH; Phutrakul S; Chen ST
Proteomics; 2011 Jun; 11(11):2162-70. PubMed ID: 21538882
[TBL] [Abstract][Full Text] [Related]
19. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
Hirano T; Kato H
Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
[TBL] [Abstract][Full Text] [Related]
20. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
